| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | - | 13.429 | 100.643 |
| Total Income - EUR | - | - | - | - | - | - | - | - | 13.429 | 100.644 |
| Total Expenses - EUR | - | - | - | - | - | - | - | - | 14.842 | 89.430 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | - | -1.413 | 11.214 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | - | -1.413 | 9.456 |
| Employees | - | - | - | - | - | - | - | - | 1 | 1 |
Check the financial reports for the company - Cherafarm 22 S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | - | 396 | 284 |
| Current Assets | - | - | - | - | - | - | - | - | 20.563 | 31.492 |
| Inventories | - | - | - | - | - | - | - | - | 18.287 | 21.997 |
| Receivables | - | - | - | - | - | - | - | - | 1.822 | 7.822 |
| Cash | - | - | - | - | - | - | - | - | 454 | 1.673 |
| Shareholders Funds | - | - | - | - | - | - | - | - | -1.372 | 8.091 |
| Social Capital | - | - | - | - | - | - | - | - | 40 | 40 |
| Debts | - | - | - | - | - | - | - | - | 22.331 | 23.685 |
| Income in Advance | - | - | - | - | - | - | - | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Cherafarm 22 S.r.l.